Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06655454 · ClinicalTrials.gov registry record · Phase 2

Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment

A Phase 2 study of Quality of Life (QOL) and Pain Assessment, sponsored by New York University.

Recruiting
Registry status
Phase 2
Development phase
150
Enrollment target
1
Study location

NCT06655454 is a Phase 2 study of Quality of Life (QOL) and Pain Assessment that is actively recruiting participants, run by New York University. The registered enrollment target is 150 participants, above the 103-participant average among 3 other Quality of Life (QOL) trials with a reported enrollment target (46% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06655454, a Phase 2 study of Quality of Life (QOL) and Pain Assessment, is actively recruiting participants, sponsored by New York University.

RECRUITING
Registry status
Phase 2
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The study will investigate the impact of an additional injection of long-acting anesthetic on pain level, quality of life, and use of pain medication after a nonsurgical endodontic treatment. The long-acting anesthetic will be compared to a mock injection group and a group with no additional anesthetic to determine any differences in effects.

Interventions

  • DRUG Supplemental Postoperative Bupivacaine
  • DRUG Placebo Injection

Study Locations (1)

New York

  • New York University College of Dentistry - New York

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-11-01
Est. Completion 2025-12-01
Phase Phase 2

Sponsor

New York University

83 total trials

What the Registry Record Tells You About NCT06655454

The ClinicalTrials.gov registry entry for NCT06655454 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 103-participant average among 3 other Quality of Life (QOL) trials with a reported enrollment target (46% higher). The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Quality of Life (QOL) appearing as the primary indexed condition, and to 2 interventions - of which Supplemental Postoperative Bupivacaine is the first listed.

NCT06655454 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06655454 about?

NCT06655454 is a clinical study titled "Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment". The study will investigate the impact of an additional injection of long-acting anesthetic on pain level, quality of life, and use of pain medication after a nonsurgical endodontic treatment. The long-acting anesthetic will be compared to a mock injection group and a group with no additional anesthe...

What is the current status of trial NCT06655454?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2024-11-01. Estimated completion is 2025-12-01.

What conditions does trial NCT06655454 study?

This clinical trial studies the following conditions: Quality of Life (QOL), Pain Assessment, Analgesic Use.

What interventions are being tested in trial NCT06655454?

The interventions under investigation include: Supplemental Postoperative Bupivacaine (DRUG), Placebo Injection (DRUG).

Who is sponsoring clinical trial NCT06655454?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06655454 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life (QOL)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.